IRCT2014050517581N1 IRCT 2015-02-13 Shiraz University of Medical Sciences Evaluation of the efficacy of ginger in reduction chemotherapy-induced nausea and vomiting in newly diagnosed breast cancer patients receiving doxorubicin(adriamycin)-based chemotherapy. Evaluation of the efficacy of ginger in reduction chemotherapy-induced nausea and vomiting in newly diagnosed breast cancer patients receiving doxorubicin(adriamycin)-based chemotherapy. 2014-08-06 anticipated 110 Complete https://irct.ir/trial/16131 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. 3 Breast cancer. Intervention 1: Intervention group: all patients with new breast cancer that assigned to this group randomly, should have Complete Blood Count before any cycle of chemotherapy and all of them receive standard anti-emetic treatment concurrent their chemotherapy (doxorubicin-based) then they receive additional anti-emetic treatment in this manner: 1) capsule ginger 250mg 2) 2 capsule (500 mg) every 12 hours 3) for 3 days in every cycle of chemotherapy 4) for 3 cycles of chemotherapy. Intervention 2: Control group: all patients with new breast cancer that assigned to this group randomly, should have Complete Blood Cell before any cycle of chemotherapy and all of them receive standard anti-emetic treatment concurrent their chemotherapy(doxorubicin-based) then they receive additional anti-emetic treatment in this manner: 1)placebo capsule that has similar shape and size with ginger 250mg capsule 2) 2 capsule every 12 hours 3) for 3 days in every cycle of chemotherapy 4) for 3 cycles of chemotherapy.